Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Finegold

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
European Journal of Preventive Cardiology|September 19, 2014
What proportion of symptomatic side-effects in patients taking statins are genuinely caused by the drug? A response to lettersJudith A Finegold, Darrel P Francis
Journal of the American College of Cardiology|May 13, 2014
Reply: application of the gompertz method for evaluating survival gains in patients receiving cardiac resynchronization therapyJudith A Finegold, Darrel P Francis
International Journal of Cardiology|December 11, 2012
Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United NationsJudith A Finegold, Perviz Asaria, Darrel P Francis
BMJ (Clinical Research Ed.)|April 9, 2010
A pain in the neckJudith A Finegold, Rosemary Belcher, Shahid Noor, et al.
Journal of the American College of Cardiology|August 31, 2013
Quantification of survival gain from cardiac resynchronization therapy: nonlinear growth with time, and greater gain in low-risk patients, make raw trial data an underestimate of real-world behaviorJudith A Finegold, Claire E Raphael, Wayne C Levy, et al.
European Journal of Preventive Cardiology|March 14, 2014
What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choiceJudith A Finegold, Charlotte H Manisty, Ben Goldacre, et al.
International Journal of Cardiology|May 6, 2014
2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United NationsAlexandra N Nowbar, James P Howard, Judith A Finegold, et al.
International Journal of Cardiology|May 12, 2012
Choosing between velocity-time-integral ratio and peak velocity ratio for calculation of the dimensionless index (or aortic valve area) in serial follow-up of aortic stenosisJudith A Finegold, Charlotte H Manisty, Fabrizio Cecaro, et al.
International Journal of Cardiology|December 4, 2014
Grateful receipt of clarifications on a perioperative trial: an illustration of the duty of readers to ask questionsGraham D Cole, Matthew J Shun-Shin, Judith A Finegold, et al.
International Journal of Cardiology|February 4, 2014
International RCT-based guidelines for use of preoperative stress testing and perioperative beta-blockers and statins in non-cardiac surgeryAlexandra N Nowbar, Graham D Cole, Matthew J Shun-Shin, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Preventive Cardiology|September 19, 2014
What proportion of symptomatic side-effects in patients taking statins are genuinely caused by the drug? A response to lettersJudith A Finegold, Darrel P Francis
Journal of the American College of Cardiology|May 13, 2014
Reply: application of the gompertz method for evaluating survival gains in patients receiving cardiac resynchronization therapyJudith A Finegold, Darrel P Francis
International Journal of Cardiology|December 11, 2012
Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United NationsJudith A Finegold, Perviz Asaria, Darrel P Francis
BMJ (Clinical Research Ed.)|April 9, 2010
A pain in the neckJudith A Finegold, Rosemary Belcher, Shahid Noor, et al.
Journal of the American College of Cardiology|August 31, 2013
Quantification of survival gain from cardiac resynchronization therapy: nonlinear growth with time, and greater gain in low-risk patients, make raw trial data an underestimate of real-world behaviorJudith A Finegold, Claire E Raphael, Wayne C Levy, et al.
European Journal of Preventive Cardiology|March 14, 2014
What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choiceJudith A Finegold, Charlotte H Manisty, Ben Goldacre, et al.
International Journal of Cardiology|May 6, 2014
2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United NationsAlexandra N Nowbar, James P Howard, Judith A Finegold, et al.
International Journal of Cardiology|May 12, 2012
Choosing between velocity-time-integral ratio and peak velocity ratio for calculation of the dimensionless index (or aortic valve area) in serial follow-up of aortic stenosisJudith A Finegold, Charlotte H Manisty, Fabrizio Cecaro, et al.
International Journal of Cardiology|December 4, 2014
Grateful receipt of clarifications on a perioperative trial: an illustration of the duty of readers to ask questionsGraham D Cole, Matthew J Shun-Shin, Judith A Finegold, et al.
International Journal of Cardiology|February 4, 2014
International RCT-based guidelines for use of preoperative stress testing and perioperative beta-blockers and statins in non-cardiac surgeryAlexandra N Nowbar, Graham D Cole, Matthew J Shun-Shin, et al.
Pageof 3